DOTAREM gadoteric acid 279.32mg/mL injection 10mL vial 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 10ml vial

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: water for injections; meglumine - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

DOTAREM gadoteric acid 279.32mg/mL injection 15mL vial 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 15ml vial

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

DOTAREM gadoteric acid 279.32mg/mL injection 20mL vial 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dotarem gadoteric acid 279.32mg/ml injection 20ml vial

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).